MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended Sept. 30, 2022.
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021.
MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has completed a Drug Master File (DMF) process for CBD Active Pharmaceutical Ingredient (API) for the US Federal Drug Administration (FDA).
Cannabis Movers & Shakers: MediPharm Labs, Kannaway, Affinor Growers, The Weldon Project
MediPharm Labs Announces Board Shake-Up
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced changes to its board of directors Tuesday.
Avicanna Expands Medical Cannabis Brand RHO Phyto Into Caribbean Region With Export To Barbados
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, has successfully expanded its Rho Phyto-branded medical cannabis products into the Car
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021.
Contents
Cannabis Movers & Shakers: Urban-Gro, MediPharm Labs, RWB, Isracann Biosciences, MedMen
Former Crop One and Sensei Ag CEO Sonia Lo Joins Urban-Gro’s Board Of Directors
Urban-gro, Inc. (NASDAQ: UGRO) announced Thursday that Sonia Lo agreed to join the company’s board of directors.
MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced Thursday it has appointed Bryan Howcroft as chief executive officer and director, effective November 15, 2021.
MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF), a pharmaceutical company specialized in cannabis, has announced that McMaster University, a partner of the company, has been given permission by Health Canada to conduct a clinical trial using some of MediPharm’s c